Your browser doesn't support javascript.
loading
Combining the dual antibacterial and regenerative activities of platelet-rich plasma with ß-lactams to mitigate MRSA-infected skin wounds.
Yang, Shih-Chun; Lin, Chwan-Fwu; Alshetaili, Abdullah; Aljuffali, Ibrahim A; Chien, Min-Yu; Fang, Jia-You.
Affiliation
  • Yang SC; Department of Microbiology, Soochow University, Taipei, Taiwan.
  • Lin CF; Research Center for Food and Cosmetic Safety and Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Kweishan, Taoyuan, Taiwan; Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; Department of Cosmetic Science, Chang Gung University
  • Alshetaili A; Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj, Saudi Arabia.
  • Aljuffali IA; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Chien MY; Pharmaceutics Laboratory, Graduate Institute of Natural Products, Chang Gung University, Kweishan, Taoyuan, Taiwan.
  • Fang JY; Research Center for Food and Cosmetic Safety and Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Kweishan, Taoyuan, Taiwan; Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; Pharmaceutics Laboratory, Graduate Institute of Natur
Biomed Pharmacother ; 165: 115017, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37327588
The emergence of multidrug-resistant bacteria contributes to the necessity of developing novel infection treatment approaches. This study was designed to evaluate the antimicrobial and wound healing activities of platelet-rich plasma (PRP) in combination with ß-lactams (ampicillin and/or oxacillin) for the application on methicillin-resistant Staphylococcus aureus (MRSA)-infected skin. PRP was collected from the peripheral blood of healthy donors. The anti-MRSA activity was tested through a growth inhibition curve, colony-forming unit (CFU), and SYTO 9 assay. The PRP incorporation lowered the minimum inhibitory concentration (MIC) of ampicillin and oxacillin against MRSA. The combination of ß-lactams together with PRP showed a three-log CFU reduction of MRSA. The major components of PRP for eliminating MRSA were found to be the complement system and iron sequestration proteins, according to the proteomic analysis. The adhesive bacterial colony in the microplate was decreased from 2.9 × 107 to 7.3 × 105 CFU after the treatment of cocktails containing ß-lactams and PRP. The cell-based study indicated that keratinocyte proliferation was stimulated by PRP. The in vitro scratch and transwell experiments revealed that PRP improved keratinocyte migration. In the MRSA-infected mouse skin model, PRP appeared to show a synergistic effect for wound area reduction by 39% when combined with ß-lactams. The MRSA burden in the infected area was lessened two-fold after topical administration of the combined ß-lactams and PRP. PRP inhibited macrophage infiltration in the wound site to shorten the inflammatory phase and accelerate the initiation of the proliferative phase. No skin irritation was detected with the topical delivery of this combination. Our findings suggested that ß-lactams plus PRP was applicable to alleviate the problems associated with MRSA via dual antibacterial and regenerative activities.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Wound Infection / Platelet-Rich Plasma / Methicillin-Resistant Staphylococcus aureus Type of study: Prognostic_studies Limits: Animals Language: En Journal: Biomed Pharmacother Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Wound Infection / Platelet-Rich Plasma / Methicillin-Resistant Staphylococcus aureus Type of study: Prognostic_studies Limits: Animals Language: En Journal: Biomed Pharmacother Year: 2023 Document type: Article Affiliation country: Country of publication: